Literature DB >> 31981714

Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report.

M-A Barbet-Massin1, V Rigalleau2, P Blanco2, K Mohammedi2, P Poupon2, E Belin3, N Poursac2, O Cadart2, L Blanco2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31981714     DOI： 10.1016/j.diabet.2020.01.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  1 in total

1.  Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream.

Authors:  Shannon Nugent; Alexandra J Coromilas; Joseph C English; Misha Rosenbach
Journal:  JAAD Case Rep       Date:  2022-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.